Emerald Bioscience (OTC: EMBI)
Dr. Brian Murphy, CEO
Dr. Brian Murphy, CEO of Emerald Bioscience, will host a featured presentation to update investors and analysts. Emerald Bioscience (EMBI) is a biopharmaceutical company headquartered in Long Beach, California, focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Emerald's strategy is to clinically develop a number of proprietary biosynthetic compounds, alone or in combination with corporate partners.